Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.
Press releases published on October 2, 2025
October 2, 2025
Newsmatics Turns 30: Online News Pioneer Launches Giveaway to Celebrate Three Decades of Innovation
Indeterminate
EIN Presswire
October 2, 2025
DP Gayatri and RS Americas Announce Strategic Alliance to Deliver Integrated Industrial Manufacturing Solutions
Indeterminate
EIN Presswire
October 2, 2025
Hyperbaric Oxygen Therapy Shows New Promise for Traumatic Brain Injury Patients
Indeterminate
EIN Presswire
October 2, 2025
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.
Indeterminate
GlobeNewswire
October 2, 2025
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
October 2, 2025
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
October 2, 2025
Cardiff Oncology to Participate in Two Upcoming Investor Conferences
Indeterminate
GlobeNewswire
October 2, 2025
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
Indeterminate
GlobeNewswire
October 2, 2025
Tenaya Therapeutics to Participate in Upcoming October Investor Conferences
Indeterminate
GlobeNewswire
October 2, 2025
Venus Concept Announces $11.48 Million Debt-to-Equity Exchange Transaction
Indeterminate
GlobeNewswire
October 2, 2025
Dyne Therapeutics Appoints Brian Posner to its Board of Directors
Indeterminate
GlobeNewswire
October 2, 2025
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
October 2, 2025
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
October 2, 2025
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
Indeterminate
GlobeNewswire
October 2, 2025
Corvus Pharmaceuticals Appoints David Moore to Board of Directors
Indeterminate
GlobeNewswire